“Requiring Members of the House of Representatives and the Senate to participate in random drug testing.”
No CRS summary available for this bill.
This section establishes the short title as the “Exposing Congressional Drug Abuse Act.”
This section establishes a program requiring each Member of the House of Representatives and the Senate to participate in random drug testing for illegal use of controlled substances once per term. It requires that each confirmed positive result be provided to the affected Member and, for House Members, to the House Committee on Ethics, or, for Senate Members, to the Senate Select Committee on Ethics for any necessary review under chamber rules. It also directs the relevant ethics committees to publicly disclose the identity of any Member who refuses to participate and to take other appropriate action, and requires each Member to reimburse the House or Senate for the cost of the test. As background, the provision defines a controlled substance by reference to section 102 of the Controlled Substances Act (21 U.S.C. 802), defines a confirmed positive result as an initial positive test that is confirmed by a second test using a different chemical process and certified by a medical review officer, and defines a random drug test as a periodic, unannounced test conducted without individualized suspicion.